Eastern Asia: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2024

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Eastern Asia

In 2022, the East Asian market for medicaments of alkaloids or derivatives thereof increased by X% to $X, rising for the seventh consecutive year after two years of decline. The total consumption indicated temperate growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2015 indices. Over the period under review, the market reached the peak level in 2022 and is likely to continue growth in the immediate term.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Eastern Asia

In value terms, production of medicaments of alkaloids or derivatives thereof shrank modestly to $X in 2022 estimated in export price. The total production indicated resilient growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2019 indices. The most prominent rate of growth was recorded in 2018 when the production volume increased by X%. The level of production peaked at $X in 2019; however, from 2020 to 2022, production remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports in Eastern Asia

Exports of medicaments of alkaloids or derivatives thereof dropped slightly to X tons in 2022, approximately mirroring the year before. In general, exports saw a drastic downturn. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. Over the period under review, the exports of hit record highs at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, exports of medicaments of alkaloids or derivatives thereof expanded rapidly to $X in 2022. Overall, exports continue to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2014 when exports increased by X%. As a result, the exports attained the peak of $X. From 2015 to 2022, the growth of the exports of remained at a somewhat lower figure.

Exports by Country

The shipments of the one major exporters of medicaments of alkaloids or derivatives thereof, namely Hong Kong SAR, represented more than two-thirds of total export.

Hong Kong SAR was also the fastest-growing in terms of the medicaments of alkaloids or derivatives thereof exports, with a CAGR of X% from 2012 to 2022. From 2012 to 2022, the share of Hong Kong SAR increased by X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Hong Kong SAR ($X) also remains the largest medicaments of alkaloids or derivatives thereof supplier in Eastern Asia.

In Hong Kong SAR, exports of medicaments of alkaloids or derivatives thereof increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

The export price in Eastern Asia stood at $X per ton in 2022, picking up by X% against the previous year. Export price indicated a strong increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for medicaments of alkaloids or derivatives thereof increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2013 when the export price increased by X% against the previous year. The level of export peaked in 2022 and is expected to retain growth in the near future.

As there is only one major export destination, the average price level is determined by prices for Hong Kong SAR.

From 2012 to 2022, the rate of growth in terms of prices for Hong Kong SAR amounted to X% per year.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports in Eastern Asia

In 2022, the amount of medicaments of alkaloids or derivatives thereof imported in Eastern Asia was estimated at X tons, growing by X% on the previous year's figure. In general, imports, however, continue to indicate a abrupt downturn. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. Over the period under review, imports of reached the peak figure at X tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.

In value terms, imports of medicaments of alkaloids or derivatives thereof rose markedly to $X in 2022. Over the period under review, imports, however, saw a perceptible contraction. The pace of growth appeared the most rapid in 2016 when imports increased by X%. As a result, imports attained the peak of $X. From 2017 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

Japan represented the key importing country with an import of about X tons, which amounted to X% of total imports. South Korea (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Hong Kong SAR (X%). Taiwan (Chinese) (X tons) followed a long way behind the leaders.

From 2012 to 2022, the biggest increases were recorded for Taiwan (Chinese) (with a CAGR of X%), while purchases for the other leaders experienced mixed trends in the imports figures.

In value terms, Japan ($X) constitutes the largest market for imported medicaments of alkaloids or derivatives thereof in Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by South Korea ($X), with a X% share of total imports. It was followed by Taiwan (Chinese), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Japan totaled X%. The remaining importing countries recorded the following average annual rates of imports growth: South Korea (X% per year) and Taiwan (Chinese) (X% per year).

Import Prices by Country

In 2022, the import price in Eastern Asia amounted to $X per ton, with an increase of X% against the previous year. Import price indicated buoyant growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for medicaments of alkaloids or derivatives thereof increased by X% against 2019 indices. The pace of growth appeared the most rapid in 2015 an increase of X% against the previous year. The level of import peaked in 2022 and is expected to retain growth in years to come.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Taiwan (Chinese) ($X per ton), while Hong Kong SAR ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Japan (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :